Estimating the Impact of State Budget Cuts and Redirection of Prevention Resources on the HIV Epidemic in 59 California Local Health Departments

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Lin, Feng ^a   Lasry, Arielle ^a   Sansom, Stephanie L ^a   Wolitski, Richard J ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BUDGET; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE TRANSMISSION; ECONOMIC ASPECT; EPIDEMIC; FEMALE; FUNDING; HEALTH CARE COST; HEALTH CARE FINANCING; HEALTH CARE PLANNING; HEALTH IMPACT ASSESSMENT; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PUBLIC HEALTH SERVICE; QUANTITATIVE ANALYSIS; RESOURCE ALLOCATION; UNITED STATES;

BUDGETS; DELIVERY OF HEALTH CARE; FEMALE; HEALTH CARE COSTS; HIV INFECTIONS; HUMANS; LOS ANGELES; MALE; SAN FRANCISCO;

EID: 84874767758     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055713     Document Type: Article

References (55)

1. Centers for Disease Control and Prevention (2011) HIV surveillance-United States, 1981-2008. MMWR Morb Mortal Wkly Rep 60: 689-693.
2. Prejean J, Song R, Hernandez A, Ziebell R, Green T, et al. (2011) Estimated HIV Incidence in the United States, 2006-2009. PLoS One 6: e17502.
3. Office of National AIDS Policy (2010) National HIV/AIDS Strategy for the United States. Office of National AIDS Policy.
4. The Kaiser Family Foundation, National Association of State and Territorial Apprenticeship Directors (NASTAD) (2009) National HIV Prevention Inventory. The Kaiser Family Foundation and NASTAD.
5. The Kaiser Family Foundation (2011) U.S. Federal Funding for HIV/AIDS: The President's FY 2012 Budget Request. The Kaiser Family Foundation.
6. National Association of State and Territorial Apprenticeship Directors (NASTAD), National Coalition of STD Directors (NCSD) (2011) 2010 State General Revenue Cuts IN HIV/AIDS, STD and Viral Hepatitis Programs. NASTAD and NCSD.
7. Leibowitz AA, Mendes AC, Desmond K, (2011) Public funding of HIV/AIDS prevention, treatment, and support in California. J Acquir Immune Defic Syndr 58: e11-16.
8. Arnold EA, Galindo GR, Gaffney S, Steward WT, Morin SF (2010) Examining the Impact of the HIV-related State Budget Cuts: Comparing Alameda, Fresno, and Los Angeless Counties. In: AIDS Policy Research Center UoC-SF, Foundation SFA, Inform P, editors.
9. Centers for Disease Control and Prevention (2010) HIV Surveillance Report. 2009: 21.
10. Pinkerton SD, Abramson P.R. (1998) The Bernoulli-process model of HIV transmission. In: Holtgrave D, editor. Handbook of Economic Evaluation of HIV Prevention Programs: Springer.
11. Marks G, Crepaz N, Senterfitt JW, Janssen RS, (2005) Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr 39: 446-453.
12. Camoni L, Dal Conte I, Regine V, Colucci A, Chiriotto M, et al. (2011) Sexual behaviour reported by a sample of Italian MSM before and after HIV diagnosis. Ann Ist Super Sanita 47: 214-219.
13. Marks G, Millett GA, Bingham T, Bond L, Lauby J, et al. (2009) Understanding differences in HIV sexual transmission among Latino and black men who have sex with men: The Brothers y Hermanos Study. AIDS Behav 13: 682-690.
14. Centers for Disease Control and Prevention (2011) Vital Signs: HIV Prevention Through Care and Treatment- United States. MMWR Morb Mortal Wkly Rep 60: 1618-1623.
15. Torian LV, Wiewel EW, (2011) Continuity of HIV-related medical care, New York City, 2005-2009: Do patients who initiate care stay in care? AIDS Patient Care STDS 25: 79-88.
16. Healthy Living Project Team (2007) Effects of a behavioral intervention to reduce risk of transmission among people living with HIV: the healthy living project randomized controlled study. J Acquir Immune Defic Syndr 44: 213-221.
17. Fisher JD, Fisher WA, Cornman DH, Amico RK, Bryan A, et al. (2006) Clinician-delivered intervention during routine clinical care reduces unprotected sexual behavior among HIV-infected patients. J Acquir Immune Defic Syndr 41: 44-52.
18. Kalichman SC, Rompa D, Cage M, DiFonzo K, Simpson D, et al. (2001) Effectiveness of an intervention to reduce HIV transmission risks in HIV-positive people. Am J Prev Med 21: 84-92.
19. Rotheram-Borus MJ, Swendeman D, Comulada WS, Weiss RE, Lee M, et al. (2004) Prevention for substance-using HIV-positive young people: telephone and in-person delivery. J Acquir Immune Defic Syndr 37Suppl 2: S68-77.
20. Wingood GM, DiClemente RJ, Mikhail I, Lang DL, McCree DH, et al. (2004) A randomized controlled trial to reduce HIV transmission risk behaviors and sexually transmitted diseases among women living with HIV: The WiLLOW Program. J Acquir Immune Defic Syndr 37Suppl 2: S58-67.
21. Crosby R, Diclemente RJ, Yarber WL, (2009) Correlates of Correct Condom Use Among High-Risk African American Men Attending an Urban STD Clinic in the South. Int J Sex Health 21: 183-191.
22. Jemmott LS, Jemmott JB 3rd, O'Leary A, (2007) Effects on sexual risk behavior and STD rate of brief HIV/STD prevention interventions for African American women in primary care settings. Am J Public Health 97: 1034-1040.
23. Scholes D, McBride CM, Grothaus L, Civic D, Ichikawa LE, et al. (2003) A tailored minimal self-help intervention to promote condom use in young women: results from a randomized trial. AIDS 17: 1547-1556.
24. Schackman BR, Gebo KA, Walensky RP, Losina E, Muccio T, et al. (2006) The lifetime cost of current human immunodeficiency virus care in the United States. Med Care 44: 990-997.
25. Centers for Disease Control and Prevention (2011) Results of the Expanded HIV Testing Initiative-25 jurisdictions, United States, 2007-2010. MMWR Morb Mortal Wkly Rep 60: 805-810.
26. Centers for Disease Control and Prevention (2011) HIV Testing at CDC-Funded Sites, United States, Puerto Rico, and the U.S. Virgin Islands, 2008-2009. In: Prevention CfDCa, editor. Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention.
27. The California State Office of AIDS (2009) Office of AIDS FY2009-10 Budget Implementation Plan. The California State Office of AIDS.
28. Holtgrave DR, Anderson T, (2004) Utilizing HIV transmission rates to assist in prioritizing HIV prevention services. Int J STD AIDS 15: 789-792.
29. Holtgrave DR, Curran JW, (2006) What works, and what remains to be done, in HIV prevention in the United States. Annu Rev Public Health 27: 261-275.
30. Lasry A, Sansom SL, Hicks KA, Uzunangelov V, (2012) Allocating HIV Prevention Funds in the United States: Recommendations from an Optimization Model. PLoS One 7: e37545.
31. Centers for Disease Control and Prevention (2012) Funding Opportunity Announcement (FOA) PS12-1201: Comprehensive Human Immunodeficiency Virus (HIV) Prevention Programs for Health Departments. In: Divisions of HIV/AIDS Prevention NCfHA, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, editor.
32. Holtgrave DR, (2010) On the epidemiologic and economic importance of the National AIDS Strategy for the United States. J Acquir Immune Defic Syndr 55: 139-142.
33. Centers for Disease Control and Prevention (2001) HIV Prevalence Trends in Selected Populations in the United States: Results from National Serosurveillance, 1993-1997. Atlanta, GA: Prevention Services Research Branch, Division of HIV/AIDS Prevention-Surveillance and Epidemiology, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention.
34. Friedman SR, Lieb S, Tempalski B, Cooper H, Keem M, et al. (2005) HIV among injection drug users in large US metropolitan areas, 1998. J Urban Health 82: 434-445.
35. Xia Q, Osmond DH, Tholandi M, Pollack LM, Zhou W, et al. (2006) HIV prevalence and sexual risk behaviors among men who have sex with men: results from a statewide population-based survey in California. J Acquir Immune Defic Syndr 41: 238-245.
36. Boily MC, Baggaley RF, Wang L, Masse B, White RG, et al. (2009) Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis 9: 118-129.
37. Baggaley RF, White RG, Boily MC, (2010) HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention. Int J Epidemiol 39: 1048-1063.
38. Baggaley RF, Boily MC, White RG, Alary M, (2006) Risk of HIV-1 transmission for parenteral exposure and blood transfusion: a systematic review and meta-analysis. AIDS 20: 805-812.
39. Chandra A, Mosher WD, Copen C, Sionean C (2011) Sexual behavior, sexual attraction, and sexual identity in the United States: data from the 2006-2008 National Survey of Family Growth. Natl Health Stat Report: 1-36.
40. Metsch L, Zhao W, Lalota M, Beck D, Forrest D,et al. Serosorting Practices among Injection Drug Users (IDUs) in South Florida; 2007 National HIV Prevention Conference; Atlanta, Georgia.
41. Sanchez T, Finlayson T, Drake A, Behel S, Cribbin M, et al. (2006) Human immunodeficiency virus (HIV) risk, prevention, and testing behaviors-United States, National HIV Behavioral Surveillance System: men who have sex with men, November 2003-April 2005. MMWR Surveill Summ 55: 1-16.
42. Fortenberry JD, Schick V, Herbenick D, Sanders SA, Dodge B, et al. (2010) Sexual behaviors and condom use at last vaginal intercourse: a national sample of adolescents ages 14 to 17 years. J Sex Med 7Suppl 5: 305-314.
43. Herbenick D, Reece M, Schick V, Sanders SA, Dodge B, et al. (2010) Sexual behaviors, relationships, and perceived health status among adult women in the United States: results from a national probability sample. J Sex Med 7Suppl 5: 277-290.
44. Reece M, Herbenick D, Schick V, Sanders SA, Dodge B, et al. (2010) Sexual behaviors, relationships, and perceived health among adult men in the United States: results from a national probability sample. J Sex Med 7Suppl 5: 291-304.
45. Grigoryan A, Shouse RL, Durant T, Mastro TD, Espinoza L, et al. (2010) HIV Infection Among Injection-Drug Users-34 States, 2004-2007 (Reprinted from MMWR, vol 58, pg 1291-1295, 2009). Jama-Journal of the American Medical Association 303: 126-128.
46. Lansky A, Drake A, Pham HT, (2009) HIV-Associated Behaviors Among Injecting-Drug Users-23 Cities, United States, May 2005-February 2006 (Reprinted from MMWR, vol 58, pg 329-332, 2009). Jama-Journal of the American Medical Association 302: 376-377.
47. Reece M, Herbenick D, Schick V, Sanders SA, Dodge B, et al. (2010) Condom use rates in a national probability sample of males and females ages 14 to 94 in the United States. J Sex Med 7Suppl 5: 266-276.
48. Finlayson TJ, Le B, Smith A, Bowles K, Cribbin M, et al. (2011) HIV risk, prevention, and testing behaviors among men who have sex with men-National HIV Behavioral Surveillance System, 21 U.S. cities, United States, 2008. MMWR Surveill Summ 60: 1-34.
49. Weller S, Davis K (2002) Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database Syst Rev: CD003255.
50. Bunnell R, Ekwaru JP, Solberg P, Wamai N, Bikaako-Kajura W, et al. (2006) Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda. AIDS 20: 85-92.
51. Del Romero J, Castilla J, Hernando V, Rodriguez C, Garcia S, (2010) Combined antiretroviral treatment and heterosexual transmission of HIV-1: cross sectional and prospective cohort study. BMJ 340: c2205.
52. Donnell D, Baeten JM, Kiarie J, Thomas KK, Stevens W, et al. (2010) Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet 375: 2092-2098.
53. Attia S, Egger M, Muller M, Zwahlen M, Low N, (2009) Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. Aids 23: 1397-1404.
54. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, et al. (2011) Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 365: 493-505.
55. Sanders GD, Bayoumi AM, Sundaram V, Bilir SP, Neukermans CP, et al. (2005) Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy. N Engl J Med 352: 570-585.